Miller Value Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-388,380
| Closed | -$42M | – | 91 |
|
|
2019
Q4 | $42M | Sell |
388,380
-60,400
| -13% | -$6.53M | 1.49% | 34 |
|
|
2019
Q3 | $44M | Hold |
448,780
| – | – | 1.77% | 29 |
|
|
2019
Q2 | $58.8M | Buy |
448,780
+1,100
| +0.2% | +$144K | 2.24% | 22 |
|
|
2019
Q1 | $60.5M | Sell |
447,680
-455
| -0.1% | -$61.5K | 2.4% | 21 |
|
|
2018
Q4 | $43.6M | Sell |
448,135
-690
| -0.2% | -$67.2K | 1.98% | 25 |
|
|
2018
Q3 | $62.4M | Buy |
448,825
+6,480
| +1% | +$901K | 2.01% | 23 |
|
|
2018
Q2 | $54.9M | Buy |
442,345
+21,280
| +5% | +$2.64M | 2.05% | 26 |
|
|
2018
Q1 | $46.9M | Sell |
421,065
-15,800
| -4% | -$1.76M | 1.96% | 21 |
|
|
2017
Q4 | $52.2M | Sell |
436,865
-7,560
| -2% | -$904K | 2.22% | 23 |
|
|
2017
Q3 | $62.3M | Sell |
444,425
-6,300
| -1% | -$884K | 2.68% | 18 |
|
|
2017
Q2 | $54.8M | Buy |
450,725
+92,025
| +26% | +$11.2M | 2.22% | 20 |
|
|
2017
Q1 | $43.5M | Buy |
358,700
+258,990
| +260% | +$31.4M | 1.91% | 22 |
|
|
2016
Q4 | $12.2M | Buy |
+99,710
| New | +$12.2M | 0.54% | 33 |
|